The dual-targeting CAR T-cell therapy KITE-363 showed positive response rates and manageable side effects in relapsed or ...

Ernexa Therapeutics’ “Trojan Horse” stem cells can infiltrate ovarian tumors in mice, boosting T cell activity and leading to ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Kite Pharma’s bicistronic CAR T-cell therapy hit the main goal of a phase 1a trial, with zero dose-limiting toxicities (DLTs) ...

David Shook, MD appointed as Chief Medical Officer, Mark Meltz, JD as General Counsel and Corporate Secretary, and Jarrad ...

A Falmouth teen, Jayden Wilsey, is the first to receive gene therapy to treat sickle cell at Boston Children's Hospital.

CAR T cell therapy is an approach in which scientists genetically ... An important disease marker called “free light chain” returned to normal for every patient within 7 to 15 days. In 8 out of 9 ...

Fifteen companies skyrocketed by double to triple digits last week, buoyed by fresh company-specific developments and a ...

For over a decade, scientists have been growing organoids - small clusters of cells that mimic a particular organ - to serve ...